Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Family-oriented setup guidance to allocate every dollar and align spending with collective priorities.
19,524 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A sharp spike in local impact fees in Manatee County jeopardizes Live Local housing projects as developers and lawmak...
A 69-year-old employee demonstrates a practical path to postponing required minimum distributions by remaining with h...
Micron’s blowout quarter ignited a rally that dwarfed many peers, but the broader memory-chip sector lifted a key ETF...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
SpaceX has sparked huge investor curiosity, but buying SpaceX stock before the next move requires a disciplined plan....
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
A proposed bill would end the Social Security earnings test for those under full retirement age, potentially increasi...